This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings.
| Name | Shares | Options |
|---|---|---|
| Pioneer Pharma (Singapore) Pte. Ltd. | 274,161 | 0 |
| China Pioneer Pharma Holdings Ltd By Pioneer Pharma (Singapore) Pte. Ltd. | 200,161 | 0 |
| Pioneer Pharma (Hong Kong) Co Ltd By Pioneer Pharma (Singapore) Pte. Ltd. | 200,161 | 0 |
| Pioneer Pharma (Hong Kong) Co Ltd | 148,240 | 0 |
| Fu Jian Ping | 114,285 | 0 |
| Najafi Ramin Ownership through the Najafi Family Trust | 96,904 | 0 |
| NAQU AREA PIONEER PHARMA CO., LTD. Shares are held directly by Pioneer Pharma (Singapore) Pte. Ltd. Pioneer Pharma (Singapore) Pte. Lt | 57,142 | 0 |
| Li Xinzhou The shares are held by Pioneer Pharma (Singapore) Pte. Ltd., a 100% wholly owned subsidiary of Naqu | 22,857 | 0 |
| China Pioneer Pharma Holdings Ltd | 12,199 | 0 |
| SIECZKAREK MARK M | 5,613 | 58,692 |
| Tufts Robert R. By the Robert R. Tufts and Joyce A. Tufts Trust dated September 18, 1987 | 5,557 | 0 |
| Jones Andrew D. | 3,641 | 714 |
| Hall Justin | 2,376 | 10,000 |
| PAULSON THOMAS J | 1,948 | 0 |
| Stroman David W. | 657 | 0 |
| Najafi Ramin Individual Retirement Account | 342 | 0 |
| Wicks Tony D.S. By the Tony D. Wicks and Anne K. Wicks Revocable Trust | 0 | 0 |
| Tufts Robert R. | 0 | 0 |
| Li Xinzhou | 0 | 25,248 |
| LIU XIAOYAN | 0 | 0 |
| Freiman Paul E. PAUL FREIMAN & ANNA MAZZUCHI FREIMAN TTEES PAUL FREIMAN & ANNA MAZZUCHI FREIMAN TR U/A DTD 5 | 0 | 0 |
| Bley Keith R | 0 | 0 |
| Cashion Charles By the Charles J. Cashion and Martha Diane Cashion Trust u/d/t dated July 27, 1998 | 0 | 0 |
| 0 | 0 | |
| Wang Xiaopei | 0 | 0 |
| Ma Yonghao | 0 | 43,629 |
| Najafi Ramin Najafi Family Trust | 0 | 0 |
| Law Tommy | 0 | 0 |
| Freiman Paul E. By the Paul Freiman and Anna Mazzuchi Freiman Trust dated 5/24/95 | 0 | 0 |
| McGovern John Joseph | 0 | 190,000 |
| Garlikov Julie | 0 | 30,000 |
| Najafi Ramin | 0 | 0 |
| Li Xinzhou By Pioneer Pharma (Singapore) Pte. Ltd. | 0 | 0 |
| Tufts Robert R. ROBERT R TUFTS & JOYCE A TUFTS TR ROBERT & JOYCE TUFTS TRUST UA 09/18/87 | 0 | 0 |
| Sit Swan | 0 | 30,000 |
| Dailley Anthony By the Anthony and Terry Dailley Trust, u/a/d 07/12/1991 | 0 | 0 |
| McPherson T. Alex | 0 | 537,279 |
| Maderis Gail J | 0 | 84,213 |
| NAQU AREA PIONEER PHARMA CO., LTD. Pioneer Pharma (Singapore) Pte. Ltd. a 100% wholly-owned subsidiary of Naqu Area Pioneer Pharma Co. | 0 | 0 |
| Freiman Paul E. By the Paul Freiman and Anna Mazzuchi Freiman Trust | 0 | 0 |
| Wicks Tony D.S. | 0 | 301,016 |
| STUART LEWIS J | 0 | 0 |
| Dailley Anthony | 0 | 0 |
| Hoon Russell A. | 0 | 0 |
| China Pioneer Pharma Holdings Ltd By Pioneer Pharma (Singapore)Pte. Ltd. | 0 | 0 |
| Xu Wang By Spouse | 0 | 0 |
| Anderson Mark Brian | 0 | 0 |
| Najafi Family Trust dated September 13, 2006 By the Najafi Family Trust dated September 13, 2006 | 0 | 0 |
| Zheng Yongxiang | 0 | 30,000 |
| Li Xinzhou The warrants are held by Pioneer Pharma (Singapore) Pte. Ltd., a 100% wholly owned subsidiary of Naq | 0 | 0 |
| Liu Yanbin | 0 | 20,000 |
| WU MIJIA Spouse | 0 | 0 |
| Raleigh Jason Philip | 0 | 0 |
| Kunin Jeffrey | 0 | 0 |
| Khosrovi Behzad | 0 | 0 |
| NAQU AREA PIONEER PHARMA CO., LTD. Pioneer Pharma (Singapore) Pte. Ltd. is a 100% wholly-owned subsidiary of Naqu Area Pioneer Pharma C | 0 | 0 |
| Scott Colin | 0 | 0 |
| Dailley Anthony By the Anthony Dailley DDS Profit Sharing Plan | 0 | 0 |
| Zheng Yenyou | 0 | 30,000 |
| Xu Wang | 0 | 75,000 |
| WU ROY J | 0 | 0 |
| Zavodnick Todd Erik | 0 | 53,698 |
| Cashion Charles | 0 | 377,156 |
| Radaelli Massimo | 0 | 45,000 |
| Dailley Anthony By the Anthony & Terry Dailley Trust, u/a/d 1991 | 0 | 0 |
| Freiman Paul E. | 0 | 30,000 |
| WU MIJIA | 0 | 30,000 |
| Kunin Audrey | 0 | 0 |
While Insider sales are normal part of tax harvesting and is part of compensation of executives - A large number of transactions would indicate that the management isnt convinced that the price will go up and hence reducing their holding. This would be a possible indicator or fall in price
| Name | Shares | Price | Date |
|---|
Insider buys arent usual, since it indicates a high conviction by the management that they believe the price will go up eventually. Usually a good sign that investors should consider this as a factor to purchase a stock, especially if the current SP is lower than the price the management bought these at. The table below doesnt include any Stock Options or RSUs. They're just open market purchases by the insiders.
| Name | Shares | Price | Date |
|---|